Effects of coronavirus disease 2019 in patients with optic neuritis: a single-centre retrospective cohort study
Open Access
- 29 July 2025
- journal article
- clinical trial-article
- Published by Springer Nature in Neurological Sciences
- Vol. 46 (10) , 5401-5411
Abstract
Background: The relationship between coronavirus disease 2019 (COVID-19) and optic neuritis (ON) remains unclear, with limited evidence on its clinical features and outcomes. This study aimed to investigate the impact of COVID-19 on ON subtypes and prognosis. Methods: We conducted a single-centre retrospective cohort study, comparing acute ON patients with and without recent COVID-19 infection during the omicron wave (December 2022 to January 2023). A historical control group from the pre-COVID-19 era was included for comparison. Results: A total of 55 ON patients were included, of whom 12 had recent COVID-19 infection. COVID-19-associated ON showed a higher incidence of acute disseminated encephalomyelitis-associated ON (ADEM-ON, 25% vs. 0%) and a lower rate of aquaporin-4 antibody-associated ON (AQP4-ON, 0% vs. 31.4%). These patients presented more frequently with eye pain (75%) and respiratory symptoms (60%). At onset, 66.7% experienced severe visual loss (mean logMAR 1.10 ± 0.71), but most (83.3%) achieved good visual recovery (mean logMAR 0.08 ± 0.44) after immunotherapy. Only one relapse was observed during follow-up. Conclusions: COVID-19 may trigger distinct autoimmune processes in ON, particularly increasing ADEM-ON prevalence. Despite initial severe vision loss, outcomes are generally favourable with timely treatment. These findings expand understanding of neuro-ophthalmic complications related to COVID-19.Keywords
Funding Information
- National Natural Science Foundation of China (82271384)
This publication has 30 references indexed in Scilit:
- Optic Neuritis and Cranial Neuropathies Diagnosis Rates before Coronavirus Disease 2019, in the Initial Pandemic Phase, and Post-Vaccine IntroductionOphthalmology, 2023
- Central nervous system complications in SARS-CoV-2-infected patientsJournal of Neurology, 2023
- Atypical myelin oligodendrocyte glycoprotein antibody–associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature reviewJournal of Neuroimmunology, 2022
- Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis with COVID-19 infection: A case report and literature reviewAmerican Journal of Ophthalmology Case Reports, 2022
- Optic neuritis post-COVID-19 infection. A case report with meta-analysisInterdisciplinary Neurosurgery, 2021
- Optic neuritis concomitant with pituitary macroadenoma in a patient with active COVID-19 infection: A case reportInternational Journal of Surgery Open, 2021
- The diagnostic dilemma of bilateral optic neuritis and idiopathic intracranial hypertension coexistence in a patient with recent COVID‐19 infectionClinical Case Reports, 2021
- Optic neuritis following SARS-CoV-2 infectionJournal of NeuroVirology, 2021
- Neuromyelitis optica spectrum disorder after presumed coronavirus (COVID-19) infection: A case reportMultiple Sclerosis and Related Disorders, 2020
- COVID-19 and the central nervous systemClinical Neurology and Neurosurgery, 2020